NCT02565368View on ClinicalTrials.gov

A Clinical Study to Compare the Pharmacokinetic Characteristics of CKD-395 0.5/1000 mg in Healthy Male Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

July 31, 2015

Primary Completion Date

August 31, 2015

Study Completion Date

August 31, 2015

Conditions
Diabetes Mellitus, Type II
Interventions
DRUG

Duvie Tab. 0.5mg, Glucophage XR Tab. 1000mg

single oral administration

DRUG

CKD-395 0.5/1000mg

single oral administration

Trial Locations (1)

Unknown

Chonbuk National University Hospital, Jeonju

Sponsors
All Listed Sponsors
lead

Chong Kun Dang Pharmaceutical

INDUSTRY